<VariationArchive VariationID="234991" VariationName="NM_000117.3(EMD):c.153dup (p.Ser52fs)" VariationType="Duplication" Accession="VCV000234991" Version="10" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-02-20" DateCreated="2016-06-03" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="236822" VariationID="234991">
      <GeneList>
        <Gene Symbol="EMD" FullName="emerin" GeneID="2010" HGNC_ID="HGNC:3331" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154379295" stop="154381523" display_start="154379295" display_stop="154381523" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153607596" stop="153609882" display_start="153607596" display_stop="153609882" Strand="+" />
          </Location>
          <OMIM>300384</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000117.3(EMD):c.153dup (p.Ser52fs)</Name>
      <CanonicalSPDI>NC_000023.11:154379754:CCCCCC:CCCCCCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>Xq28</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154379754" stop="154379755" display_start="154379754" display_stop="154379755" variantLength="1" positionVCF="154379754" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153608114" stop="153608115" display_start="153608114" display_stop="153608115" variantLength="1" positionVCF="153608114" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
      </Location>
      <ProteinChange>S52fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_745" sequenceAccession="LRG_745">
            <Expression>LRG_745:g.10325dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000117.2" sequenceAccession="NM_000117" sequenceVersion="2" change="c.153dupC">
            <Expression>NM_000117.2:c.153dupC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.153608120dup" Assembly="GRCh37">
            <Expression>NC_000023.10:g.153608120dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.154379760dup" Assembly="GRCh38">
            <Expression>NC_000023.11:g.154379760dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008677.1" sequenceAccession="NG_008677" sequenceVersion="1" change="g.10325dup">
            <Expression>NG_008677.1:g.10325dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000117.3" sequenceAccession="NM_000117" sequenceVersion="3" change="c.153dup" MANESelect="true">
            <Expression>NM_000117.3:c.153dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000108.1" sequenceAccession="NP_000108" sequenceVersion="1" change="p.Ser52fs">
            <Expression>NP_000108.1:p.Ser52fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA10581192" DB="ClinGen" />
        <XRef Type="rs" ID="876661345" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000117.3(EMD):c.153dup (p.Ser52fs) AND not provided" Accession="RCV000223909" Version="2">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2013-07-31" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000117.3(EMD):c.153dup (p.Ser52fs) AND Cardiovascular phenotype" Accession="RCV000246169" Version="2">
        <ClassifiedConditionList TraitSetID="32616">
          <ClassifiedCondition DB="MedGen" ID="CN230736">Cardiovascular phenotype</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2013-07-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000117.3(EMD):c.153dup (p.Ser52fs) AND X-linked Emery-Dreifuss muscular dystrophy" Accession="RCV000697180" Version="8">
        <ClassifiedConditionList TraitSetID="6541">
          <ClassifiedCondition DB="MedGen" ID="C0751337">X-linked Emery-Dreifuss muscular dystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-14" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2016-06-03" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">17620497</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21697856</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24365856</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="32616" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33389" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Cardiovascular phenotype</ElementValue>
              </Name>
              <XRef ID="CN230736" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6541" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="15903" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">X-linked Emery-Dreifuss muscular dystrophy</ElementValue>
                <XRef ID="MONDO:0010680" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Muscular dystrophy, tardive Emery-Dreifuss type, with contractures</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Emery-Dreifuss muscular dystrophy (EDMD) is characterized by the clinical triad of: joint contractures that begin in early childhood; slowly progressive muscle weakness and wasting initially in a humero-peroneal distribution that later extends to the scapular and pelvic girdle muscles; and cardiac involvement that may manifest as palpitations, presyncope and syncope, poor exercise tolerance, and congestive heart failure along with variable cardiac rhythm disturbances. Age of onset, severity, and progression of muscle and cardiac involvement demonstrate both inter- and intrafamilial variability. Clinical variability ranges from early onset with severe presentation in childhood to late onset with slow progression in adulthood. In general, joint contractures appear during the first two decades, followed by muscle weakness and wasting. Cardiac involvement usually occurs after the second decade and respiratory function may be impaired in some individuals.</Attribute>
                <XRef ID="NBK1436" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2102" />
                <XRef ID="2102" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301609</ID>
                <ID Source="BookShelf">NBK1436</ID>
              </Citation>
              <XRef ID="261" DB="Orphanet" />
              <XRef ID="98863" DB="Orphanet" />
              <XRef ID="C0751337" DB="MedGen" />
              <XRef ID="MONDO:0010680" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="528586" SubmissionDate="2016-05-06" DateLastUpdated="2016-06-03" DateCreated="2016-06-03">
        <ClinVarSubmissionID localKey="NM_000117.2:c.153dupC|Not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000280100" DateUpdated="2016-06-03" DateCreated="2016-06-03" Type="SCV" Version="1" SubmitterName="Stanford Center for Inherited Cardiovascular Disease, Stanford University" OrgID="505443" OrganizationCategory="clinic" OrgAbbreviation="SCICD" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2013-07-31">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Note this variant was found in clinical genetic testing performed by one or more labs who may also submit to ClinVar. Thus any internal case data may overlap with the internal case data of other labs. The interpretation reviewed below is that of the Stanford Center for Inherited Cardiovascular Disease. Based on the information below, we consider this variant very likely pathogenic. The c.153dupC EMD variant, located on exon 2, results from a duplication of cysteine at position 153, causing a translational frameshift with a predicted premature stop codon. This variant was identified in a 9 year old boy with a clinical diagnosis of limb girdle muscular dystrophy, with absence of emerin on IHC staiining of skeletal muscle biopsy tissue (Ura et al., 2007). This patient had a normal echocardiogram. Brown and colleagues (Brown et al., 2011) studied 225 participants referred for genetic screening following a clinical diagnosis of EDMD, limb-girdle muscular dystrophy, Becker muscular dystrophy or FSHD. FHL1, SYNE1 and SYNE2 mutations were not screened, as the screening programme predated linkage of these genes to the EDMD phenotype. They reported eight novel mutations including six frameshift mutations (p.D9GfsX24, p.F39SfsX17, p.R45KfsX16, p.F190YfsX19, p.R203PfsX34 and p.R204PfsX7) and two non-sense mutations (p.S143X and p.W200X) Brown et al. also identified exon 2 as a hot spot for mutations in the EMD gene. The three most common mutations identified in exon 2 were at codon 51 resulting in p.S52AfsX13 (4 hits; stop at codon 64) and p.Y34X (3 hits). Four of the 18 (22%) probands had mutations in exon 2, of which two are novel but with one also targeting residue S52. Frameshift mutations in the EMD gene have been previously shown to allow modified emerin expression, suggest the shortest length required for protein expression is 208 residues, which is 94% (208/221) of the nucleoplasmic domain length, as shown by the in vivo expression of the p.P169RfsX40 mutation. From this, we can predict that three of our novel mutations (p.F190YfsX19, p.R203PfsX34 and p.R204PfsX7) will express truncated forms of erroneous protein, with the remaining mutations preventing protein expression. There is no variation at codon 52 listed in the NHLBI Exome Sequencing Project dataset, which currently includes variant calls on ~6,500 Caucasian and African American individuals (as of 8/1/13).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="3" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EMD" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000117.2:c.153dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>5_6_2016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="600446" SubmissionDate="2020-11-30" DateLastUpdated="2016-10-02" DateCreated="2016-10-02">
        <ClinVarSubmissionID localKey="a86780" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000318752" DateUpdated="2016-10-02" DateCreated="2016-10-02" Type="SCV" Version="5" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2013-07-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.153dupC pathogenic mutation, located in coding exon 2 of the EMD gene, results from a duplication of cysteine at position 153, causing a translational frameshift with a predicted premature stop codon. In one study, this alteration was identified in a 9 year old boy with clinical diagnosis of limb girdle muscular dystrophy (LGMD), who had absence of emerin on immunohistochemical staining of skeletal muscle biopsy tissue. Clinical features at age 9 included Gowers sign, waddling gait, proximal dominant limb muscle weakness and atrophy, transient sinus arrhythmia on electrocardiogram, but no joint contractures and a normal echocardiogram (Ura etal. Arch. Neurol. 2007;64:1038-1041). This alteration was also identified in a series of patients referred for genetic testing due to a suspected diagnosis of Emery-Dreiffuss muscular dystrophy (EDMD). Authors identify exon 2 as a hot spot for mutations in the EMD gene (Brown etal. J. Hum. Genet. 2011;56:589-594). In addition, alterations causing a translational frameshift are typically deleterious in nature (ACMG Recommendations for Standards for Interpretation and Reporting of Sequence Variations. Revision 2007. Genet Med. 2008;10:294). Based on available evidence, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Autosomal Dominant and X-Linked criteria (10/2015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/zfkfvckw/mid-7377_ambry_classification_scheme_oct_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EMD" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000117.2:c.153dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Cardiovascular phenotype</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="CN230736" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>NonExomeUpdate_081220AmbryReport</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1597588" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2018-10-10">
        <ClinVarSubmissionID localKey="4030566|MedGen:C0751337" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000825777" DateUpdated="2024-02-14" DateCreated="2018-10-10" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">24365856</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17620497</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21697856</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Ser52Glnfs*9) in the EMD gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EMD are known to be pathogenic (PMID: 24365856). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with Emery-Dreifuss muscular dystrophy and limb-girdle muscular dystrophy (PMID: 17620497, 21697856). This variant is also known as c.153_154insC. ClinVar contains an entry for this variant (Variation ID: 234991). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EMD" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.153608114_153608115insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0751337" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB5371970</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="528586" TraitType="Disease" MappingType="Name" MappingValue="Not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1597588" TraitType="Disease" MappingType="XRef" MappingValue="C0751337" MappingRef="MedGen">
        <MedGen CUI="C0751337" Name="X-linked Emery-Dreifuss muscular dystrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="600446" TraitType="Disease" MappingType="Name" MappingValue="Cardiovascular phenotype" MappingRef="Preferred">
        <MedGen CUI="CN230736" Name="Cardiovascular phenotype" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

